Live symbol workspace

PRGO market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $14.64

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$13.91

Resistance

$15.37

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$14.64

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

50%

No prior-week baseline yet

Avg confidence across 2 calls in the last 7 days

What sources say

Neutral 1 article

H.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising Pharma

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

PRGO News Intelligence (1 articles)

AI-curated news influencing PRGO price, sentiment, and trend

Explore All PRGO News with AI Analysis

Global Markets & Finance

1 hour, 50 minutes ago

H.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising Pharma

H.I.G. Capital is exploring options for its controlling stake in US-based Rising Pharmaceuticals, including a possible sale, according to people …

Impact on PRGO: The article does not provide direct evidence of market impact, but a …

H.I.G. Capital is considering a sale of its controlling stake in Rising Pharmaceuticals, a US-based … High (70%)

View full analysis →

Bloomberg 70% confidence